Literature DB >> 1362016

Extracellular matrix formation by epithelial cells from human polycystic kidney cysts in culture.

G Candiano1, R Gusmano, P Altieri, R Bertelli, F Ginevri, D A Coviello, A Sessa, G Caridi, G M Ghiggeri.   

Abstract

Cells from the cysts of patients with autosomal dominant polycystic kidney disease (PKD) were grown in vitro under standard conditions without the aid of collagen-pretreated surfaces, and both the synthesis and composition of the extracellular matrix were investigated. At confluence, PKD cells presented the typical features of epithelial cells, but showed a different collagen composition from fibroblasts. Compared with normal tubular epithelia (NTE), PKD monolayers produced an excess of extracellular matrix, which accounted for 30% of the total incorporation of [3H] proline, although this value was considerably lower (by a factor of 10) in the case of NTE. Immunohistochemical and electrophoretic techniques revealed a complex collagen composition in the extracellular matrix which included [alpha (III)]3 and collagen IV. However, part of the collagen components remained unidentified in spite of the fact that they exhibited a typical M(r) of alpha 1(I) and alpha 2(I) in the presence of urea. Immunoprecipitation with monospecific antibodies and Northern blotting with specific probes failed to recognize alpha 1(I) and alpha 2(I), but demonstrated their presence in fibroblasts. Purification and cyanogen bromide digestion demonstrated a strong interhomology in fingerprint peptide composition among the uncharacterized collagens synthesized by PKD cells, thus suggesting a common identity. These observations document a markedly augmented production of extracellular matrix by PKD cultured cells in vitro, and show the presence of collagens which do not share homologies with the major collagen molecules. A better characterization of extracellular matrix composition is central to any comprehension of the cytogenetic mechanisms in vivo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1362016     DOI: 10.1007/bf02899238

Source DB:  PubMed          Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol        ISSN: 0340-6075


  7 in total

1.  The ADPKD genes pkd1a/b and pkd2 regulate extracellular matrix formation.

Authors:  Steve Mangos; Pui-ying Lam; Angela Zhao; Yan Liu; Sudha Mudumana; Aleksandr Vasilyev; Aiping Liu; Iain A Drummond
Journal:  Dis Model Mech       Date:  2010-03-24       Impact factor: 5.758

2.  Inactivation of integrin-β1 prevents the development of polycystic kidney disease after the loss of polycystin-1.

Authors:  Kyung Lee; Sylvia Boctor; Laura M C Barisoni; G Luca Gusella
Journal:  J Am Soc Nephrol       Date:  2014-08-21       Impact factor: 10.121

3.  Circulating anti-actin and anti-ATP synthase antibodies identify a sub-set of patients with idiopathic nephrotic syndrome.

Authors:  L Musante; G Candiano; M Bruschi; L Santucci; B Carnemolla; P Orecchia; M Giampuzzi; C Zennaro; S Sanna-Cherchi; M Carraro; R Oleggini; G Camussi; F Perfumo; G M Ghiggeri
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

Review 4.  Extracellular matrix, integrins, and focal adhesion signaling in polycystic kidney disease.

Authors:  Yan Zhang; Gail Reif; Darren P Wallace
Journal:  Cell Signal       Date:  2020-04-18       Impact factor: 4.315

Review 5.  Polycystins, focal adhesions and extracellular matrix interactions.

Authors:  Iain A Drummond
Journal:  Biochim Biophys Acta       Date:  2011-03-09

6.  Increasing extracellular matrix collagen level and MMP activity induces cyst development in polycystic kidney disease.

Authors:  Bin Liu; Chenghai Li; Zijuan Liu; Zonghan Dai; Yunxia Tao
Journal:  BMC Nephrol       Date:  2012-09-11       Impact factor: 2.388

7.  Effects of PEP-1-FK506BP on cyst formation in polycystic kidney disease.

Authors:  Hyo Sang Jo; Won Sik Eum; Eun Young Park; Je Young Ko; Do Yeon Kim; Dae Won Kim; Min Jea Shin; Ora Son; Su Bin Cho; Jung Hwan Park; Chi Hern Lee; Eun Ji Yeo; Hyeon Ji Yeo; Yeon Joo Choi; Jong Kyu Youn; Sung-Woo Cho; Jinseu Park; Jong Hoon Park; Soo Young Choi
Journal:  BMB Rep       Date:  2017-09       Impact factor: 4.778

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.